Aptamer Group PLC (AIM:APTA)
London · Delayed Price · Currency is GBP · Price in GBX 0.9125
+0.0125 (1.39%)
Jan 22, 2026, 3:39 PM GMT
Aptamer Group Market Cap
Aptamer Group has a market cap or net worth of 24.27 million as of January 22, 2026. Its market cap has increased by 283.02% in one year.
Market Cap
24.27M
Enterprise Value
23.70M
Revenue
1.20M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.91
Market Cap Chart
Since December 22, 2021, Aptamer Group's market cap has decreased from 97.55M to 24.27M, a decrease of -75.12%. That is a compound annual growth rate of -28.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 24.27M | -16.28% |
| Dec 31, 2025 | 28.99M | 308.04% |
| Dec 31, 2024 | 7.11M | 32.20% |
| Dec 29, 2023 | 5.37M | -84.73% |
| Dec 30, 2022 | 35.20M | -62.04% |
| Dec 31, 2021 | 92.73M | -4.95% |
| Dec 22, 2021 | 97.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 215.42B |
| GSK plc | 72.86B |
| Haleon | 32.41B |
| Smith & Nephew | 10.28B |
| Convatec Group | 4.51B |
| Hikma Pharmaceuticals | 3.48B |
| HUTCHMED (China) | 2.00B |
| Genus | 1.90B |